# Safety Study of Modified Vaccinia Virus to Cancer

> **NCT00574977** · PHASE1 · COMPLETED · sponsor: **David Bartlett** · enrollment: 26 (actual)

## Conditions studied

- Melanoma
- Breast Cancer
- Head and Neck Squamous Cell Cancer
- Liver Cancer
- Colorectal Cancer
- Pancreatic Adenocarcinoma

## Interventions

- **BIOLOGICAL:** Vaccinia virus (vvDD-CDSR)
- **BIOLOGICAL:** Vaccinia virus (vvDD-CDSR)
- **BIOLOGICAL:** Vaccinia virus (vvDD-CDSR)

## Key facts

- **NCT ID:** NCT00574977
- **Lead sponsor:** David Bartlett
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2013-01
- **Final completion:** 2014-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574977, "Safety Study of Modified Vaccinia Virus to Cancer". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT00574977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*